IntraLinks announced the results of the IntraLinks Global Investigator Site Survey. The survey looked at what methods are currently used for clinical trial document exchange, and the effectiveness of those methods. Eighty three percent of the respondents were clinical research coordinators, investigators and subinvestigators.
The survey findings show that the majority of investigator sites are using traditional methods–e-mail, courier, and fax–as a primary tool for clinical trial document exchange. A relatively small number of respondents are using web-based document exchange tools as their primary method:
· 73% of respondents use traditional methods – email (52%), courier (12%) and fax (nine percent)–as their primary tool for clinical trial document exchange
· 25% of respondents use web-based document exchange tools as their main way of exchanging clinical trial documents
The survey results indicate that investigator sites are experiencing significant inefficiencies and productivity challenges as a result of the ongoing use of email, courier and fax:
· 59% of respondents track due dates for information, current status or milestones manually
· 66% of respondents spend at least two hours, and in some cases more than nine hours, per week searching for documents
· 74% of respondents report resending documents to sponsors and Contract Research Organizations (CROs) at least once or twice, and in some cases more than five times, a week
The survey found that respondents recognize the benefits of web-based clinical document exchange tools:
· 68% of respondents cited being able to access updated information right away and reducing the amount of paper they use as advantages
· 62% of respondents cited being able to keep track of information easily as a benefit
· 47% of respondents cited not spending as much time searching for information as a benefit
The survey findings also showed that most respondents are conducting numerous studies and those that use online clinical tools such as electronic data capture and clinical portals have a significant number of passwords and logins:
· 87% of respondents have conducted three to 15+ studies over the last 12 months
· 57% of respondents are running four to 15+ concurrent studies
· 47% of respondents have at least three to ten passwords and logins, while another 20% have more than ten
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.